To our immune system, potentially life-saving gene therapy can look like a dangerous infection. This is because most genetic medicines use viruses or double-stranded DNA to deliver genetic information to target cells. DNA in its traditional double helix form can give rise to toxic immune stimulation and can be difficult to package into cellular delivery vehicles. As a result, access to genetic therapy is limited today.

